Research Papers

25 of 5901 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Biowarfare Pathogens. Is the Research Flavor Different Than That of Clinically Relevant Pathogens?
Lee VJ.
Unknown Journal
Published: 2004
1/6 Transparent
Funding Declared
Treatment goals: response and nonresponse.
Macher JP; Crocq MA.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Imaging dopamine neurotransmission in Parkinson's disease: biomarker versus surrogate end point.
Innis RB.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Mild cognitive impairment: historical development and summary of research.
Golomb J; Kluger A; Ferris SH.
Dialogues Clin Neurosci (Unknown)
Published: 2004
1/6 Transparent
Funding Declared
Poor response to treatment: beyond medication.
Carvajal C.
Unknown Journal
Published: 2004
Texture analysis of the brain: from animal models to human applications.
Nedelec JF; Yu O; Chambron J; Macher JP.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Sex-dependent modulation of treatment response.
Rubinow DR; Moore M.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Pharmacotherapy of mild cognitive impairment.
Gauthier S.
Unknown Journal
Published: 2004
Structural plasticity of the adult brain.
Gage FH.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects.
Ackenheil M; Weber K.
Dialogues Clin Neurosci (Unknown)
Published: 2004
CSF tau and β-amyloid as biomarkers for mild cognitive impairment.
Hampel H; Blennow K.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking.
Du J; Quiroz JA; Gray NA; Szabo ST; Zarate CA; Manji HK.
Unknown Journal
Published: 2004
The future of genetic testing for drug response.
Morris-Rosendahl DJ; Fiebich BL.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Mild cognitive impairment: an epidemiological perspective.
Ritchie K.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Neural plasticity: consequences of stress and actions of antidepressant treatment.
Duman RS.
Dialogues Clin Neurosci (Unknown)
Published: 2004
1/6 Transparent
Funding Declared
Treatment-refractory schizophrenia.
Caspi A; Davidson M; Tamminga CA.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Neuropsychological methods in mild cognitive impairment.
Hahn-Barma V; Chamayou C; Rogan C; Sarazin M; Dubois B.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Structural plasticity of the adult brain: how animal models help us understand brain changes in depression and systemic…
McEwen BS.
Dialogues Clin Neurosci (Unknown)
Published: 2004
1/6 Transparent
Funding Declared
Current perspectives in the management of treatment-resistant depression.
Parikh RM; Lebowitz BD.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Problems in texture analysis with magnetic resonance imaging.
Schad LR.
Unknown Journal
Published: 2004
Mild cognitive impairment: animal models.
Pepeu G.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Texture analysis methodologies for magnetic resonance imaging.
Materka A.
Dialogues Clin Neurosci (Unknown)
Published: 2004
Regulatory aspects of mild cognitive impairment: toward a harmonized perspective.
Whitehouse PJ.
Unknown Journal
Published: 2004
Cellular consequences of stress and depression.
Fuchs E; Flügge G.
Dialogues Clin Neurosci (Unknown)
Published: 2004
1/6 Transparent
Funding Declared
Drug treatment of Parkinson's disease.
Korczyn AD.
Unknown Journal
Published: 2004